Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Caveolae-Mediated Endocytosis Is Critical for Albumin Cellular Uptake and Response to Albumin-Bound Chemotherapy
Moumita Chatterjee, Edgar Ben‐Josef, Ryan Robb, et al.
Cancer Research (2017) Vol. 77, Iss. 21, pp. 5925-5937
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine
Mauro Sousa de Almeida, Eva Sušnik, Barbara Drašler, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 9, pp. 5397-5434
Open Access | Times Cited: 668
Harnessing albumin as a carrier for cancer therapies
Ella N. Hoogenboezem, Craig L. Duvall
Advanced Drug Delivery Reviews (2018) Vol. 130, pp. 73-89
Open Access | Times Cited: 489
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Qin Cheng, Gang Yang, Jinshou Yang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 297
Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver
Lei Miao, Jiaqi Lin, Yuxuan Huang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 250
Chemical and Biophysical Signatures of the Protein Corona in Nanomedicine
Jiayu Ren, Nikolaos K. Andrikopoulos, Kelly Velonia, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 21, pp. 9184-9205
Closed Access | Times Cited: 189
Nanocarrier‐Mediated Cytosolic Delivery of Biopharmaceuticals
Wei He, Xuyang Xing, Xiaoling Wang, et al.
Advanced Functional Materials (2020) Vol. 30, Iss. 37
Closed Access | Times Cited: 136
Drug uptake-based chemoresistance in breast cancer treatment
Helena Muley, Rut Fadó, Rosalía Rodríguez‐Rodríguez, et al.
Biochemical Pharmacology (2020) Vol. 177, pp. 113959-113959
Open Access | Times Cited: 116
Caveolin‐1, cancer and therapy resistance
Julia Ketteler, Diana Klein
International Journal of Cancer (2018) Vol. 143, Iss. 9, pp. 2092-2104
Open Access | Times Cited: 112
Albumin-Based Nanotheranostic Probe with Hypoxia Alleviating Potentiates Synchronous Multimodal Imaging and Phototherapy for Glioma
Zhenzhen Yang, Yitian Du, Qi Sun, et al.
ACS Nano (2020) Vol. 14, Iss. 5, pp. 6191-6212
Closed Access | Times Cited: 111
The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy
Hongyu Tao, Ruiqi Wang, Weijin Sheng, et al.
International Journal of Biological Macromolecules (2021) Vol. 187, pp. 24-34
Closed Access | Times Cited: 90
Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9
Hyunduk Jang, Sang Eun Lee, Jimin Yang, et al.
European Heart Journal (2019) Vol. 41, Iss. 2, pp. 239-252
Open Access | Times Cited: 86
<p>Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy</p>
Xiaowei Wang, Yuhan Qiu, Mengyan Wang, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 9447-9467
Open Access | Times Cited: 82
Caveolin-1 function at the plasma membrane and in intracellular compartments in cancer
Layla Simón, América Campos, Lisette Leyton, et al.
Cancer and Metastasis Reviews (2020) Vol. 39, Iss. 2, pp. 435-453
Open Access | Times Cited: 80
Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection
Yuan‐Bo Pan, Wei Tang, Wenpei Fan, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 23, pp. 9759-9830
Open Access | Times Cited: 70
A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance
Philipp Fronik, Michael Gutmann, Petra Vician, et al.
Communications Chemistry (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 44
Deciphering albumin-directed drug delivery by imaging
Huiyu Hu, Jeremy M. Quintana, Ralph Weissleder, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114237-114237
Open Access | Times Cited: 42
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 36
Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer
Tiantian Tan, Yuxin Feng, Weimin Wang, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 33
The role of metabolic reprogramming in pancreatic cancer chemoresistance
Chang Liu, Changfeng Li, Yuanda Liu
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 24
Roles of Albumin‐Binding Proteins in Cancer Progression and Biomimetic Targeted Drug Delivery
Pengfei Zhao, Yonghui Wang, Aihua Wu, et al.
ChemBioChem (2018) Vol. 19, Iss. 17, pp. 1796-1805
Closed Access | Times Cited: 80
Endogenous albumin-mediated delivery of redox-responsive paclitaxel-loaded micelles for targeted cancer therapy
Yujie Zhang, Zhongyuan Guo, Zhonglian Cao, et al.
Biomaterials (2018) Vol. 183, pp. 243-257
Closed Access | Times Cited: 73
Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review
Leen Van de Sande, Sarah Cosyns, Wouter Willaert, et al.
Drug Delivery (2019) Vol. 27, Iss. 1, pp. 40-53
Open Access | Times Cited: 68
<p>SPIONs enhances IL-10-producing macrophages to relieve sepsis via Cav1-Notch1/HES1-mediated autophagy</p>
Yujun Xu, Yi Li, Xinghan Liu, et al.
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 6779-6797
Open Access | Times Cited: 65
Nanoparticle albumin bound-paclitaxel for treatment of advanced non-small cell lung cancer: an evaluation of the clinical evidence
Diego Adrianzen Herrera, Nadia Ashai, Román Pérez-Soler, et al.
Expert Opinion on Pharmacotherapy (2018) Vol. 20, Iss. 1, pp. 95-102
Closed Access | Times Cited: 64
Albumin-based drug designs for pharmacokinetic modulation
Diego Pilati, Kenneth A. Howard
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 9, pp. 783-795
Closed Access | Times Cited: 64
Page 1 - Next Page

Scroll to top